Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Meet Genomic Prediction, which provides advanced genetic testing for IVF. They have developed a novel, genome-wide molecular genotyping methodology for preimplantation genetic testing of embryos.

Dr. Nathan Treff, Chief Scientific Officer at Genomic Prediction, joins us to discuss the cutting-edge technology that offers IVF parents and families a cost-effective means to evaluate genetic risks due to chromosomal abnormalities, single-gene disorders, and multi-gene disorders, known as polygenic diseases such as diabetes, cancer, and heart disease.

Their approach provides an unparalleled level of options for identifying potential disease risk in embryos and improving newborn health outcomes.

For Genomic Prediction, it’s about helping IVF parents be more knowledgeable, showing them the risks and providing options to help make the best and most informed decisions for their families.

FOP, or fibrodysplasia ossificans progressive, is one of the rarest and most disabling genetic conditions known to medicine.

At MassMutual, their priority is helping people secure their future and protect the ones they love. That's why executive Dennis Stempel is here to discuss financial tips and more. 

360training is a leading online e-learning provider. Amid the pandemic, 360training is responsible for a course on health and sanitation safety awareness. 

Comments

comments